Works matching IS 01422782 AND DT 2017 AND VI 38 AND IP 2
Results: 7
Quantifying gut wall metabolism: methodology matters.
- Published in:
- Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 2, p. 155, doi. 10.1002/bdd.2062
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 2, p. 85, doi. 10.1002/bdd.2031
- Publication type:
- Article
Inhibition of glucuronidation and oxidative metabolism of buprenorphine using GRAS compounds or dietary constituents/supplements: in vitro proof of concept.
- Published in:
- Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 2, p. 139, doi. 10.1002/bdd.2050
- By:
- Publication type:
- Article
Revisiting the role of gut wall in the fate of orally administered drugs: Why now and to what effect?
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon.
- Published in:
- Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 2, p. 94, doi. 10.1002/bdd.2072
- By:
- Publication type:
- Article
Caco-2 cells - expression, regulation and function of drug transporters compared with human jejunal tissue.
- Published in:
- Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 2, p. 115, doi. 10.1002/bdd.2025
- By:
- Publication type:
- Article
P-gp activity and inhibition in the different regions of human intestine ex vivo.
- Published in:
- Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 2, p. 127, doi. 10.1002/bdd.2047
- By:
- Publication type:
- Article